Comera Life Sciences Holdings, Inc.
CMRADelisted Feb 15, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001907685
Comera Life Sciences Holdings, Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Feb 2, 2024; 14 institutions reported holding it in 13F filings for Q3 2023, worth $194.1K in total; no superinvestor held it.
Key figures
- Market cap
- –
- Not available
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 14
- Q3 2023, +3 vs. previous quarter
- 13F value
- $194.1K
- Reported value at the end of Q3 2023
- Superinvestors holding
- 0
- At the end of Q3 2023
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2022
- $633.1K
- No comparable prior period
- Net income, FY2022
- -$18.0M
- No comparable prior period
- Free cash flow, FY2022
- -$9.80M
- No comparable prior period
- Revenue, Q3 FY2023
- $136.3K
- −42.0% year over year
Revenue flow, FY2022
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Net loss for FY2022: $18.0M (2843.8% of revenue).
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 4.33K
- Shares sold short
- Change
- 0
- 0.0% vs. previous
- Days to cover
- 123.63
- At average daily volume
Superinvestors holding CMRA, Q3 2023
Go to the superinvestors tabNo superinvestor reported holding CMRA at the end of Q3 2023.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Comera Life Sciences Holdings, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2024 (view filing)7:48 PM ET | Dec 29, 2023 | 35 daysLate | Konar Shameek and 1 otherOther: Member of 10% owner group | PPurchase | +6.14M | $0.00 | $0 | –4.09M after | Derivative2 lotsPrice outlier |
| Jan 11, 2024 (view filing)7:14 PM ET | Dec 29, 2023 | 13 daysLate | Denny George P IIIOther: Member of 10% owner group | PPurchase | +5.87M | $0.00 | $0 | –3.91M after | Derivative2 lotsPrice outlier |
| Jan 5, 2024 (view filing)5:59 PM ET | Dec 29, 2023 | 7 daysLate | Iaf, LLCOther: Member of 10% owner group | PPurchase | +11.5M | $0.00 | $0 | –7.64M after | Derivative2 lotsPrice outlier |
| Jan 3, 2024 (view filing)8:38 PM ET | Dec 29, 2023 | 5 days | Cherington Charles10% Owner | PPurchase | +31.0M | $0.00 | $0 | –20.7M after | Derivative2 lotsPrice outlier |
| Jan 3, 2024 (view filing)8:38 PM ET | Dec 27, 2023 | 7 daysLate | Cherington Charles10% Owner | PPurchase | +310.2K | $6,280.01 | +$1.95B | –3.90K after | DerivativePrice outlier |
| Jan 3, 2024 (view filing)8:09 PM ET | Dec 29, 2023 | 5 days | Huff Curtis W and 2 others10% Owner | PPurchaseCommon Stock, par value $0.0001 per share | +7.36M | $0.055 | +$134.9K | –7.36M after | Derivative2 lots |
| Jan 3, 2024 (view filing)6:30 PM ET | Dec 29, 2023 | 5 days | Soane David and 1 other10% Owner | PPurchase | +8.18M | $25,000.00 | +$204.5B | –2.73M after | Derivative4 lotsPrice outlier |
| Nov 28, 2023 (view filing)4:25 PM ET | Nov 27 | 1 day | Campbell Michael GerardEVP & CFO | PPurchase | +10.0K | $0.0708 | +$708 | +40.0%35.0K after | |
| Sep 12, 2023 (view filing)4:52 PM ET | Sep 11 | 1 day | Soane David and 1 other10% Owner | PPurchase | +117.4K | $0.5112 | +$60.0K | +70.3%284.3K after | 2 lots |
| Sep 12, 2023 (view filing)4:52 PM ET | Sep 11 | 1 day | Soane David and 1 other10% Owner | PPurchase | +293.4K | $0.00 | $0 | –146.7K after | Derivative2 lots |
Top 10 13F holders, Q3 2023
See all 14 holdersThe largest institutional positions in Comera Life Sciences Holdings, Inc. at the end of Q3 2023; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CI Private Wealth, LLC | 493,692 | $123.4K | 0.00% | +493,692 | New |
| Geode Capital Management, LLC | 70,212 | $22.4K | 0.00% | +10,204+17.0% | Added |
| HighTower Advisors, LLC | 47,600 | $14.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 44,098 | $12.9K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 29,600 | $9.44K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 17,458 | $5.57K | 0.00% | +17,458 | New |
| UBS Group AG | 8,017 | $2.33K | 0.00% | +6,366+385.6% | Added |
| Tower Research Capital LLC (TRC) | 7,338 | $2.14K | 0.00% | −24−0.3% | Reduced |
| Advisor Group Holdings, Inc. | 3,600 | $1.05K | 0.00% | −15,150−80.8% | Reduced |
| Morgan Stanley | 2,292 | $668 | 0.00% | 00.0% | Unchanged |